KK Shah Hospitals FY26 net loss widens to ₹62.27 lakh

4 min read     Updated on 18 May 2026, 10:14 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

KK Shah Hospitals Limited reported a widened net loss of ₹62.27 lakh for FY26 against ₹32.72 lakh in FY25, with total revenue rising to ₹961.71 lakh. The Board approved the audited standalone financial results and appointed M/s Jayesh Chopra & Associates as internal auditor for FY27.

powered bylight_fuzz_icon
40668240

*this image is generated using AI for illustrative purposes only.

KK Shah Hospitals Limited has announced its audited standalone financial results for the financial year ended March 31, 2026. The healthcare provider reported a net loss of ₹62.27 lakh for the full year, a significant increase from the net loss of ₹32.72 lakh recorded in the previous fiscal year.

For the half-year ended March 31, 2026, the company reported a net loss of ₹29.79 lakh. In comparison, the net loss for the half-year ended March 31, 2025, stood at ₹70.05 lakh. Total revenue for the financial year 2025-26 rose to ₹961.71 lakh, up from ₹955.40 lakh in the preceding year.

Operational Performance

Revenue from operations for the full year reached ₹942.76 lakh, compared to ₹899.86 lakh in FY25. Other income, however, declined to ₹18.94 lakh from ₹55.54 lakh in the previous year. Total expenses for the year increased to ₹1,034.55 lakh from ₹988.04 lakh in the prior year, driven by higher employee benefit expenses and depreciation.

The company's earnings per share (EPS) for the year ended March 31, 2026, was reported at -0.91, compared to -0.48 in the previous year. The paid-up equity share capital remained stable at ₹680.85 lakh.

Financial Position

The audited statement of assets and liabilities as of March 31, 2026, shows total assets at ₹1,502.60 lakh, a decrease from ₹1,597.73 lakh in the previous year. Shareholders' funds stood at ₹1,279.32 lakh, comprising share capital of ₹680.85 lakh and reserves and surplus of ₹598.47 lakh.

Particulars Year Ended 31/03/2026 (₹ in Lakhs) Year Ended 31/03/2025 (₹ in Lakhs)
Total Revenue 961.71 955.40
Total Expenses 1,034.55 988.04
Net Profit/Loss (62.27) (32.72)
Earnings Per Share (0.91) (0.48)

Board Appointments

During the board meeting held on May 18, 2026, the directors approved the appointment of M/s Jayesh Chopra & Associates, Chartered Accountants, as the internal auditor of the company for the financial year 2026-27. The firm's registration number is 036991C. The statutory auditors, M/s. A Y & Company, issued an audit report with an unmodified opinion on the financial results.

What specific projects or expansions does the Capital Work-in-Progress of ₹622.44 lakhs represent, and how will these investments impact KK Shah Hospitals' revenue capacity and profitability in FY27?

Given the sharp 66% decline in other income from ₹55.54 lakhs to ₹18.94 lakhs, what was the source of this income previously and can the company sustain even its current reduced level going forward?

With depreciation costs surging 66% year-on-year to ₹168.37 lakhs, how will the company manage its debt servicing and operational cash flows if losses continue to widen before new capacity becomes revenue-generating?

KK Shah Hospitals Schedules Board Meeting on May 18, 2026 to Approve FY26 Audited Financial Results

1 min read     Updated on 11 May 2026, 11:51 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

KK Shah Hospitals Limited has scheduled a Board of Directors meeting for May 18, 2026, to consider and approve its standalone audited financial results for the financial year ended March 31, 2026. The intimation was filed with the BSE SME Platform on May 11, 2026, under Regulation 29 of the SEBI (LODR) Regulations, 2015. The company's trading window has been closed since April 01, 2026, and will remain shut until 48 hours after the financial results are communicated to the stock exchange, in compliance with SEBI's Insider Trading regulations.

powered bylight_fuzz_icon
40026065

*this image is generated using AI for illustrative purposes only.

KK Shah Hospitals Limited (formerly known as Jeevan Parv Healthcare Limited) has notified the BSE SME Platform of an upcoming Board of Directors meeting, scheduled for Monday, May 18, 2026, at the company's registered office. The intimation was issued on May 11, 2026, in accordance with Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to transact the following business:

  • Consider and approve the Standalone Audited Financial Results for the financial year ended March 31, 2026
  • Any other business with the permission of the Chairman

The key details of the scheduled board meeting are summarised below:

Parameter: Details
Meeting Date: Monday, May 18, 2026
Intimation Date: May 11, 2026
Venue: Registered Office of the Company
Primary Agenda: Approval of Standalone Audited Financial Results for FY ended March 31, 2026
Regulatory Framework: Regulation 29, SEBI (LODR) Regulations, 2015

Trading Window Closure

In continuation of the company's earlier intimation dated March 30, 2026, KK Shah Hospitals has informed that the trading window for dealing in the equity shares of the company has been closed since April 01, 2026, pursuant to the company's Code of Conduct for Prevention of Insider Trading, framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed until 48 hours after the communication of the aforesaid financial results to the stock exchange.

The intimation was signed by Amit Shah, Managing Director (DIN: 09119113), on behalf of KK Shah Hospitals Limited.

How have KK Shah Hospitals' revenue and profitability metrics evolved since its rebranding from Jeevan Parv Healthcare Limited, and what growth trajectory might the FY2026 results reveal?

What expansion plans or capital allocation strategies could KK Shah Hospitals announce following the approval of its FY2026 audited financials?

How might the FY2026 financial results influence institutional investor interest and trading volumes in KK Shah Hospitals' BSE SME-listed shares once the trading window reopens?

More News on KK Shah Hospitals